Literature DB >> 7733826

Identification and analysis of an alcelaphine herpesvirus 1 (AHV-1) cDNA clone expressing a fusion protein recognized by AHV-1-neutralizing antisera.

R S Lahijani1, S M Sutton, R B Klieforth, W P Heuschele.   

Abstract

Rabbit antiserum to psoralen-inactivated alcelaphine herpesvirus 1 (AHV-1) virions was shown to react specifically with AHV-1-infected cells by indirect immunofluorescence. Western blot analysis using this antiserum identified a 15-kD virion protein that was also detected in infected-cell proteins between 12 and 144 h p.i., and a 37-kD protein present in infected cells between 24 and 120 h p.i. A cDNA library was constructed using mRNA obtained from AHV-1-infected fetal mouflon sheep kidney (FMSK) cells at 48 h p.i., when infected-cell proteins detected by antiserum were in abundance. Screening of the library with the rabbit anti-AHV-1 serum identified several positive clones. Southern blot analysis showed that one clone, designated 8'a, hybridized to a 4.4 kb HindIII fragment of AHV-1 DNA. This AHV-1 cDNA clone expressed a fusion protein that was recognized by serum from a naturally and asymptomatically infected white-bearded wildebeest (Connochaetes taurinus albojubatus). The insert was sequenced and found to contain 833 bp. A search of the GenBank database for related sequences revealed greater than 40% homology to several other gammaherpesviruses: herpesvirus saimiri, cottontail herpesvirus, and Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733826     DOI: 10.1007/bf01718430

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Blue wildebeest and the aetiological agent of bovine malignant catarrhal fever.

Authors:  W PLOWRIGHT; R D FERRIS; G R SCOTT
Journal:  Nature       Date:  1960-12-31       Impact factor: 49.962

2.  Modified protocol for DNA sequence analysis using Sequenase 2.0.

Authors:  R Schuurman; W Keulen
Journal:  Biotechniques       Date:  1991-02       Impact factor: 1.993

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Diagnosis of malignant catarrhal fever by polymerase chain reaction amplification of alcelaphine herpesvirus 1 sequence.

Authors:  M F Murphy; R B Klieforth; R S Lahijani; W P Heuschele
Journal:  J Wildl Dis       Date:  1994-07       Impact factor: 1.535

5.  Preliminary characterization of the alcelaphine herpesvirus 1 genome.

Authors:  A Bridgen; A J Herring; N F Inglis; H W Reid
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

6.  Nucleotide sequence of a 3.5 kilobase fragment of malignant catarrhal fever virus strain WC11.

Authors:  D Hsu; L M Shih; Y C Zee
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Alcelaphine herpesviruses 1 and 2 SDS-PAGE analysis of virion polypeptides, restriction endonuclease analysis of genomic DNA and virus replication restriction in different cell types.

Authors:  B S Seal; R B Klieforth; W H Welch; W P Heuschele
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Application of polymerase chain reaction to detect animals latently infected with agents of malignant catarrhal fever.

Authors:  R S Lahijani; S M Sutton; R B Klieforth; M F Murphy; W P Heuschele
Journal:  J Vet Diagn Invest       Date:  1994-10       Impact factor: 1.279

9.  Recovery of a herpesvirus from a roan antelope (Hippotragus equinus).

Authors:  H W Reid; A Bridgen
Journal:  Vet Microbiol       Date:  1991-08-15       Impact factor: 3.293

10.  Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.

Authors:  D C Redfield; D D Richman; M N Oxman; L H Kronenberg
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more
  1 in total

1.  Primary structure of the alcelaphine herpesvirus 1 genome.

Authors:  A Ensser; R Pflanz; B Fleckenstein
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.